How are energy investors positioned?
Investing.com - NuVasive reported on Wednesday third quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
NuVasive announced earnings per share of $0.54 on revenue of $295.3M. Analysts polled by Investing.com EPS of $0.54 on revenue of $298.74M.
NuVasive 's are up 4.35% and is trading at $37.53 , still down 40.27% from its 52 week high of $62.83 set on Monday, November 15, 2021.
NuVasive follows other major Healthcare sector earnings this month
NuVasive's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar